Based on recent data, Agios Pharmaceuticals, Inc. (AGIO) shows an Average True Range (ATR) of 1.18 and an Enterprise Value of 1.74B. Its average trading volume over the past 3 months is 1.12M, indicating liquidity. These fundamental metrics provide insight into AGIO's underlying financial health and market activity.
| ATR | 1.18 |
| Enterprise Value | 1.74B |
| Avg Vol (3 Months) | 1.12M |
| Avg Vol (10 Days) | 686.21K |
Agios Pharmaceuticals, Inc. (AGIO) technical indicators as of September 4, 2026: the SMA 20 is 6.41%, SMA 50 at 8.35%, and SMA 200 at -12.05%. The RSI 14 value is 62.23, suggesting its current momentum. These technical analysis signals help assess AGIO's price trends and potential future movements.
| SMA 20 | 6.41% |
| SMA 50 | 8.35% |
| SMA 200 | -12.05% |
| RSI 14 | 62.23 |
Agios Pharmaceuticals, Inc. (AGIO) stock performance overview as of September 4, 2026: The 52-week high is $46 (currently -34.83% below), and the 52-week low is $22.24 (currently 34.8% above). Over the past year, AGIO's performance is -16.15%, compared to the S&P 500's 1.58% change.
| 52-Week High | 46 |
| 52-Week High Chg | -34.83% |
| 52-Week Low | 22.24 |
| 52-Week Low Chg | +34.80% |
| S&P 500 52-Week Chg | 1.58% |
According to market data, Agios Pharmaceuticals, Inc. (AGIO) stock's recent performance metrics show that over the last month, AGIO is 4.83%, with a Year-to-Date (YTD) performance of -1.98%. Over the past year, the stock has seen a -16.15% change. These figures summarize AGIO's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 34.93 | 35.98 | 44.09 | 44.09 | 46 | 44.09 |
| Low | 32.92 | 31.55 | 26.89 | 24.29 | 22.24 | 24.29 |
| Performance | -5.79% | +4.83% | -36.97% | -33.17% | -16.15% | -1.98% |
According to current financial data, AGIO stock's P/E (TTM) ratio is -4.73, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.25. Key valuation ratios for AGIO, including P/S (20.15), P/B (1.92), and P/FCF (-5.43), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | AGIO | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -4.73 | -1.25 | -194.36 | 32.59 |
| P/S (TTM) | 20.15 | 3.71 | 467.56 | 5.98 |
| P/B (TTM) | 1.92 | 1.54 | 16.39 | 5.77 |
| P/FCF (TTM) | -5.43 | -1.69 | -754.77 | 29.62 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep